As expected, administering naringin at 200 mg/kg significantly improved survival in a CLP-induced mouse model of sepsis; however, naringin’s protective effect was completely abolished by pre-treatment with the HO-1 inhibitor ZnPP (Fig 7). Here, HMOX1 is linked to Sepsis.